Institutional investors purchased a net $22.5 million shares of MNKD during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 19.71% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HAREL-PIA MUTUAL FUNDS LTD. Bought 1.8 Million shares of MannKind Corp
ISZO CAPITAL MANAGEMENT LP Bought 986.7 Thousand shares of MannKind Corp
THE VANGUARD GROUP, INC. Bought 976.4 Thousand shares of MannKind Corp